How a poorly explored immune cell may impact cancer immunity and immunotherapy

November 17, 2017, University of Michigan
Tumor cells secrete lactate (blue dots) that makes contact with naïve T cells and contributes to FIP200 expression that disables the balance between pro-apoptotic and anti-apoptotic gene expression in the cells. Credit: Xia et al., Sci. Immunol. 2, eaan4631 (2017)

The immune cells that are trained to fight off the body's invaders can become defective. It's what allows cancer to develop. So most research has targeted these co-called effector T-cells.

But a new study takes a step back and considers: What if the problem isn't with the effector T-cells but starts higher up the cellular chain?

And so researchers looked at naïve T-cells - a type of immune cell that hasn't yet been triggered to fight. Naïve T-cells differentiate into the fighter effector T-cells.

"People didn't realize the problem may not only be directly from the effector cells themselves, but may also stem from a defect in the naïve cells. We found naïve cells already have a problem in patients who have cancer. If the naïve cells are functionally impaired, the cannot be healthy," says study author Weiping Zou, M.D., Ph.D., the Charles B. de Nancrede Professor of Surgery, Pathology, Immunology and Biology at the University of Michigan.

Naïve T-cells are not well understood in cancer, in part because the effector T-cells have direct control over immunity. So that's where researchers have focused their attention. Also, naïve T-cells are rare in the tumor microenvironment - the traditional battlefield between cancer and .

The new study, published in Science Immunology, finds that tumor metabolism impacts naïve T-cells. The use a lot of glucose. When the glucose is metabolized, it produces lactate - and lactate turns out to be very bad for naïve T-cells. Once the tumor produces a certain level of lactate, it causes damage to the naïve T-cells, including cell death.

Currently, efforts to predict response to immunotherapy focus on memory and effector T-cells. The new research suggests another path.

"Yes, you do see problems in effector T-cells, but you have to keep in mind that to begin with, the naïve T-cells are functionally impaired by the tumor metabolism," Zou says.

Researchers will look for ways to manipulate the metabolism to try to recover the function of the naïve T-cells in the hopes that it can make immunotherapy more effective. Some early phase clinical trials are testing a way to target the lactate pathway. Researchers hope this could provide a rationale for combining immunotherapy with a therapy to regulate metabolism.

"When you have more healthy naïve T-cells to begin with, hopefully you will get more healthy effector T-cells, which will overcome some of the resistance we see with immunotherapy," Zou says.

Explore further: Scientists discover surprising immune cell activity that may be limiting immunotherapy

More information: H. Xia el al., "Suppression of FIP200 and autophagy by tumor derived lactate promotes naïve T cell apoptosis and affects tumor immunity," Science Immunology (2017). immunology.sciencemag.org/look … 6/sciimmunol.aan4631

Related Stories

Scientists discover surprising immune cell activity that may be limiting immunotherapy

October 30, 2017
Researchers have uncovered a surprising process within a key immune cell that may help explain the limitations of immunotherapy as a cancer treatment.

Beta-adrenergic receptor signaling affects tumor microenvironment

September 13, 2017
(HealthDay)—β2-adrenergic receptor (β-AR) signaling in host immune cells regulates CD8+ T-cell frequency and functional orientation within the tumor microenvironment, according to a study published online Aug. 17 in Cancer ...

New memory for HIV patients

March 26, 2012
The hallmark loss of helper CD4+ T cells during human immunodeficiency virus (HIV) infection may be a red herring for therapeutics, according to a study published on March 26th in the Journal of Experimental Medicine.

Boosting immunity in older adults: Study unmasks new infection-fighting T cells

June 13, 2016
Sixty-five is the age when many people retire, kick back and take it easy. And so it often is with the human immune system.

Balancing T cell populations

November 25, 2013
Depending on the signals received, naïve T cells are able to differentiate into mature T cell populations, which play different roles in the immune system. For example, regulatory T cells (Tregs) are important for tamping ...

Recommended for you

New findings suggest allergic responses may protect against skin cancer

July 17, 2018
The components of the immune system that trigger allergic reactions may also help protect the skin against cancer, suggest new findings.

The immune system: T cells are built for speed

July 17, 2018
Without T cells, we could not survive. They are a key component of the immune system and have highly sensitive receptors on their surface that can detect pathogens. The exact way that these receptors are distributed over ...

Broadly acting antibodies found in plasma of Ebola survivors

July 17, 2018
Recent Ebola virus disease (EVD) outbreaks, including the 2013-2016 epidemic that ravaged West Africa and the 2018 outbreak in the Democratic Republic of the Congo, highlight the need for licensed treatments for this often-deadly ...

How protein fragments could help to tackle the cause of hay fever

July 16, 2018
Imperial researchers are looking to protein fragments to help people build up resistance to grass pollen.

Team explores diabetes drug's ability to treat RSV infection

July 13, 2018
A drug used to treat diabetes may point to new therapies for respiratory syncytial virus (RSV) bronchiolitis—inflammation and obstruction of the lungs' small airways. A multi-disciplinary team of Vanderbilt investigators ...

Testing suggests TORC1 inhibitors can boost immune system in the elderly

July 12, 2018
A team of researchers affiliated with Novartis Institutes for Biomedical Research and Biometrics Matters Limited, has found via testing with volunteers that TORC1 inhibitors can boost the immune system in the elderly. In ...

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

writehensley
not rated yet Nov 17, 2017

BUENAS NOTICIAS PARA PACIENTES INFECTADOS CON HERPES SIMPLEX VIRUS (HSV) Y VIH / SIDA ... leer

DR. (MRS) AMINGANIS es el único médico tradicional que puede curar el VIH, HERPES SIMPLEX VIRUS 1 y 2, WART, HEPATITIS, incluidas otras INFECCIONES DE LA PIEL ... Usando su 21 CURE HERBAL MEDICINE. Recientemente, un amigo mío muy cercano publicó un artículo sobre cómo se deshizo de sus herpes labiales usando el 21 CURE HERBAL MEDICINE por Dr.Mrs.Amingansi, que tomó durante 21 días. Recomiendo su medicina a personas infectadas o diagnosticadas con cualquier tipo de infección. Para aquellos que necesitan su información de contacto, simplemente puede escribirles por EMAIL o WHATSAPP:
+2349056460707
dramingansi@gmail.com
COMPARTE POR FAVOR CON AMIGOS Y PERSONAS QUE SABES QUIEN NECESITA AYUDA.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.